Pamicogrel
Alternative Names: KB 3022; KBT 3022; TO 192Latest Information Update: 20 Feb 2008
Price :
$50 *
At a glance
- Originator Nippon Organon; Torii Pharmaceutical
- Class Antiplatelets; Pyrroles; Small molecules; Thiazoles
- Mechanism of Action Cyclooxygenase inhibitors; Lipoxygenase inhibitors; Thromboxane A2 synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arterial occlusive disorders
Most Recent Events
- 16 Nov 1999 Kanebo's pharmaceutical business has been merged with Organon's Japanese operations to form Nippon Organon
- 25 Mar 1998 Preregistration for Arterial occlusive disorders in Japan (PO)
- 05 Dec 1997 Three studies have been added to the adverse events and Thromboses therapeutic trials sections ,,